Literature DB >> 21281637

Toxoplasma gondii: a bradyzoite-specific DnaK-tetratricopeptide repeat (DnaK-TPR) protein interacts with p23 co-chaperone protein.

Akio Ueno1, George Dautu, Kaori Haga, Biscah Munyaka, Gabriella Carmen, Yoshiyasu Kobayashi, Makoto Igarashi.   

Abstract

The DnaK-tetratricopeptide repeat (DnaK-TPR) gene (ToxoDB ID, TGME49_002020) is expressed predominantly at the bradyzoite stage. DnaK-TPR protein has a heat shock protein (DnaK) and tetratricopeptide repeat (TPR) domains with amino acid sequence similarity to the counterparts of other organisms (40.2-43.7% to DnaK domain and 41.1-66.0% to TPR domain). These findings allowed us to infer that DnaK-TPR protein is important in the tachyzoite-to-bradyzoite development or maintenance of cyst structure although the function of this gene is still unknown. An immunofluorescence assay (IFA) revealed that DnaK-TPR protein was expressed in Toxoplasma gondii-encysted and in vitro-induced bradyzoites and distributed in the whole part of parasite cells. We conducted yeast two-hybrid screening to identify proteins interacting with DnaK-TPR protein, and demonstrated that DnaK-TPR protein interacts with p23 co-chaperone protein (Tgp23). It was expected that DnaK-TPR protein would have a function as a molecular chaperon in bradyzoite cells associated with Tgp23. Possible mechanisms for this gene are discussed.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21281637     DOI: 10.1016/j.exppara.2011.01.015

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  9 in total

Review 1.  Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system.

Authors:  Bram Stynen; Hélène Tournu; Jan Tavernier; Patrick Van Dijck
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

Review 2.  Toxoplasma gondii Hsp90: potential roles in essential cellular processes of the parasite.

Authors:  Sergio O Angel; Maria J Figueras; Maria L Alomar; Pablo C Echeverria; Bin Deng
Journal:  Parasitology       Date:  2014-02-21       Impact factor: 3.234

Review 3.  Observations on bradyzoite biology.

Authors:  Vincent Tu; Rama Yakubu; Louis M Weiss
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

Review 4.  Mechanisms of Toxoplasma gondii persistence and latency.

Authors:  William J Sullivan; Victoria Jeffers
Journal:  FEMS Microbiol Rev       Date:  2011-10-04       Impact factor: 16.408

Review 5.  The metabolic roles of the endosymbiotic organelles of Toxoplasma and Plasmodium spp.

Authors:  Lilach Sheiner; Akhil B Vaidya; Geoffrey I McFadden
Journal:  Curr Opin Microbiol       Date:  2013-08-05       Impact factor: 7.934

6.  Divergent co-transcriptomes of different host cells infected with Toxoplasma gondii reveal cell type-specific host-parasite interactions.

Authors:  Izabela J Swierzy; Ulrike Händel; Alexander Kaever; Michael Jarek; Maren Scharfe; Dirk Schlüter; Carsten G K Lüder
Journal:  Sci Rep       Date:  2017-08-03       Impact factor: 4.379

7.  ANK1 and DnaK-TPR, Two Tetratricopeptide Repeat-Containing Proteins Primarily Expressed in Toxoplasma Bradyzoites, Do Not Contribute to Bradyzoite Differentiation.

Authors:  Jichao Yang; Lihong Zhang; Huiyan Diao; Ningbo Xia; Yanqin Zhou; Junlong Zhao; Bang Shen
Journal:  Front Microbiol       Date:  2017-11-13       Impact factor: 5.640

8.  Lactate dehydrogenase in Toxoplasma gondii controls virulence, bradyzoite differentiation, and chronic infection.

Authors:  Abdelbaset E Abdelbaset; Barbara A Fox; Mohamed H Karram; Mahmoud R Abd Ellah; David J Bzik; Makoto Igarashi
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

9.  Transcriptional Analyses Identify Genes That Modulate Bovine Macrophage Response to Toxoplasma Infection and Immune Stimulation.

Authors:  Anton Gossner; Musa A Hassan
Journal:  Front Cell Infect Microbiol       Date:  2020-08-20       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.